![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Alantos Pharmaceuticals Raises $20 Million in Private Placement
Alantos Pharmaceuticals Raises $20 Million in Private Placement
Alantos Pharmaceuticals Holding, a privately held biopharmaceutical company focused on the discovery and development of small molecule drugs with a focus on osteoarthritis/inflammation and Type II diabetes, announced it has raised $20 million in a series B private round of financing from existing investors Oxford Bioscience Partners, SV Life Sciences, Earlybird, ABN AMRO, Heidelberg Innovation and Ventech. Proceeds from the financing will be used to progress the company's pipeline of compounds, particularly its two lead candidates for diabetes and osteoarthritis into clinical development.
BioSpace (http://www.biospace.com/news_story.cfm?StoryID=19337020&full=1)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct